Prognostic factors and treatment insights for metastatic malignant phyllode tumors.

ABSTRACT:

Background

The aim of this study is to contribute a better understanding of metastatic malignant phyllode tumors (MMPTs) by exploring its prognostic factors, describing treatment landscape, and providing optimal treatment choices.

Methods

This retrospective multicentric study was included 43 patients with MMPTs who received treatment from 2009 to 2023 in four centers. The primary endpoint of the study was overall survival (OS).

Results

The median overall survival of these patients was 7.27 months (range: 0.63-118.53) and the median follow-up time was 16.8 months (range: 2-188). The median age of these patients were 49 years. The median metastasis-free survival (MFS, it is the time between initial diagnosis and diagnosis of metastatic disease) was 7.27 months, and the

SUBMITTER: Han M 

PROVIDER: S-EPMC11982053 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature